Mbx Biosciences Common Stock Market Value
| MBX Stock | 36.84 0.01 0.03% |
| Symbol | MBX |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MBX Biosciences. Expected growth trajectory for MBX significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive MBX Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
MBX Biosciences Common's market price often diverges from its book value, the accounting figure shown on MBX's balance sheet. Smart investors calculate MBX Biosciences' intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since MBX Biosciences' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that MBX Biosciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether MBX Biosciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, MBX Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
MBX Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to MBX Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of MBX Biosciences.
| 11/03/2025 |
| 02/01/2026 |
If you would invest 0.00 in MBX Biosciences on November 3, 2025 and sell it all today you would earn a total of 0.00 from holding MBX Biosciences Common or generate 0.0% return on investment in MBX Biosciences over 90 days. MBX Biosciences is related to or competes with MeiraGTx Holdings, Replimune, ArriVent BioPharma, Ginkgo Bioworks, Iovance Biotherapeutics, MoonLake Immunotherapeuti, and Erasca. MBX Biosciences is entity of United States More
MBX Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure MBX Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess MBX Biosciences Common upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.63 | |||
| Information Ratio | 0.2165 | |||
| Maximum Drawdown | 29.11 | |||
| Value At Risk | (7.47) | |||
| Potential Upside | 14.4 |
MBX Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for MBX Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as MBX Biosciences' standard deviation. In reality, there are many statistical measures that can use MBX Biosciences historical prices to predict the future MBX Biosciences' volatility.| Risk Adjusted Performance | 0.1707 | |||
| Jensen Alpha | 1.34 | |||
| Total Risk Alpha | 1.05 | |||
| Sortino Ratio | 0.2824 | |||
| Treynor Ratio | 14.32 |
MBX Biosciences February 1, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1707 | |||
| Market Risk Adjusted Performance | 14.33 | |||
| Mean Deviation | 4.51 | |||
| Semi Deviation | 3.92 | |||
| Downside Deviation | 4.63 | |||
| Coefficient Of Variation | 446.62 | |||
| Standard Deviation | 6.04 | |||
| Variance | 36.45 | |||
| Information Ratio | 0.2165 | |||
| Jensen Alpha | 1.34 | |||
| Total Risk Alpha | 1.05 | |||
| Sortino Ratio | 0.2824 | |||
| Treynor Ratio | 14.32 | |||
| Maximum Drawdown | 29.11 | |||
| Value At Risk | (7.47) | |||
| Potential Upside | 14.4 | |||
| Downside Variance | 21.41 | |||
| Semi Variance | 15.34 | |||
| Expected Short fall | (5.33) | |||
| Skewness | 0.7194 | |||
| Kurtosis | 0.7256 |
MBX Biosciences Common Backtested Returns
MBX Biosciences is not too volatile given 3 months investment horizon. MBX Biosciences Common has Sharpe Ratio of 0.19, which conveys that the company had a 0.19 % return per unit of standard deviation over the last 3 months. We have analyzed thirty different technical indicators, which can help you to evaluate if expected returns of 1.11% are justified by taking the suggested risk. Use MBX Biosciences Common downside deviation of 4.63, and Mean Deviation of 4.51 to evaluate company specific risk that cannot be diversified away. MBX Biosciences holds a performance score of 14 on a scale of zero to a hundred. The firm secures a Beta (Market Risk) of 0.0937, which conveys not very significant fluctuations relative to the market. As returns on the market increase, MBX Biosciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding MBX Biosciences is expected to be smaller as well. Use MBX Biosciences Common semi variance, as well as the relationship between the daily balance of power and price action indicator , to analyze future returns on MBX Biosciences Common.
Auto-correlation | 0.86 |
Very good predictability
MBX Biosciences Common has very good predictability. Overlapping area represents the amount of predictability between MBX Biosciences time series from 3rd of November 2025 to 18th of December 2025 and 18th of December 2025 to 1st of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of MBX Biosciences Common price movement. The serial correlation of 0.86 indicates that approximately 86.0% of current MBX Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.86 | |
| Spearman Rank Test | 0.75 | |
| Residual Average | 0.0 | |
| Price Variance | 19.31 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for MBX Stock Analysis
When running MBX Biosciences' price analysis, check to measure MBX Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MBX Biosciences is operating at the current time. Most of MBX Biosciences' value examination focuses on studying past and present price action to predict the probability of MBX Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MBX Biosciences' price. Additionally, you may evaluate how the addition of MBX Biosciences to your portfolios can decrease your overall portfolio volatility.